<DOC>
	<DOC>NCT02508922</DOC>
	<brief_summary>To build on a recent case study and open label trial, the investigators want to find out if vitamin D supplementation can influence behavioural and core symptoms of autism.</brief_summary>
	<brief_title>Trial of Vitamin D3 Supplementation in Paediatric Autism</brief_title>
	<detailed_description>The investigators will assess behavioural and core symptoms of autism before and after 20 weeks of vitamin D supplementation in a double-blind, placebo-controlled trial.</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Positive autism diagnostic observation schedule Stable medication regimen Tolerate phlebotomy Unstable or very severe autism Epilepsy Renal/liver/gastrointestinal disease</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>